About Crovalimab
Class: | Monoclonal antibody (anti-PD-1)
Use: | Treatment of adult patients with moderate to severe atopic dermatitis who are candidates for systemic therapy
Adult dose: | 340 mg administered as a subcutaneous injection once every four weeks
Pediatric dose: | Safety and efficacy have not been established in pediatric patients under 18 years of age
Side effects: | Injection site reactions, headache, fatigue, nausea, diarrhea, and increased risk of infections
Contraindications: | Hyperse
Drug Class
Monoclonal antibody (anti-PD-1)
Uses & Indications
Treatment of adult patients with moderate to severe atopic dermatitis who are candidates for systemic therapy
Storage Requirements
Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
Manufacturer & Packaging
Manufacturer: F. Hoffmann-La Roche Ltd [Basel;Switzerland], Switzerland
Package Size
1 Glass Vial (2 mL)
Price & Supplier
Price in UAE: AED 60401.50
Dosage Information
Adult Dose
340 mg administered as a subcutaneous injection once every four weeks
Pediatric Dose
Safety and efficacy have not been established in pediatric patients under 18 years of age
Side Effects
Injection site reactions, headache, fatigue, nausea, diarrhea, and increased risk of infections
Contraindications & Precautions
Hypersensitivity to crovalimab or any of its components; active infections; history of severe allergic reactions
Important Warnings
Risk of immune-mediated adverse reactions; monitor for signs of infection; may cause infusion-related reactions; not recommended for use in patients with a history of severe hypersensitivity reactions to monoclonal antibodies.
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.